-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In large population-based studies, research on the relationship between polycystic ovary syndrome (PCOS) and hypertension is very limited.
The study is a secondary analysis of longitudinal data from the Longitudinal Study of Women’s Health in Australia.
The researchers used the Cox proportional hazards model to perform survival analysis to identify predictors of hypertension, and performed a population-time analysis to calculate the incidence of hypertension.
9508 women were followed up for 145,159 person-times per year (PY), and 1556 (16.
diabetes
This shows that PCOS patients are more likely to develop hypertension in adulthood, regardless of BMI, obesity will further aggravate the condition.
PCOS patients are more likely to develop hypertension in adulthood, regardless of BMI, obesity will further aggravate the condition.
Original source:
Anju E Joham.
ncbi.
nlm.
nih.
gov/33693653/" target="_blank" rel="noopener">Incidence and Predictors of Hypertension in a Cohort of Australian Women with and without Polycystic Ovary Syndrome in this message